The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
Related Articles
Is Relative PFS Performance of Belantamab Mafodotin Adequately Reflected in MM Clinical Trials? | Blood Cancers Today
Investigators assert clinical trial design features may have contributed to this antibody-drug conjugate’s loss of approvals.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
CD19 CAR-T Therapy Offers Safe and, Effective Approach for Transformed Indolent Lymphomas | Blood Cancers Today
Charles Gaulin, MBBS, of Dartmouth Geisel School of Medicine, discussed the safety and efficacy of CD19 CAR-T cell therapy for patients with transformed indolent lymphoma.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.
Novel Immunotherapeutic Strategy May Advance Treatment for AML, MDS | Blood Cancers Today
Neoantigen-based T-cell receptor T-cell therapies are emerging as effective, antitumor treatments for patients with myeloid leukemia.
Blazing a Trail in Ph-ALL: Chemotherapy-Free Options Gain Ground | Blood Cancers Today
The pillars of recent success in the treatment of ALL include a better breakdown of high-risk subgroups and the introduction of novel therapies.
Advancing the Frontiers of Myelodysplastic Syndromes | Blood Cancers Today
Andrew Brunner, MD, discusses the latest advancements in the understanding and management of myelodysplastic syndromes, including molecular profiling and ongoing clinical trials.
Bridging the Gap: Addressing Disparities in AML Diagnosis, Treatment, and Outcomes | Blood Cancers Today
An interview with Kelly Chien, MD, conversation explores geographic and institutional differences in the standard of care, the consequences of unequal access and more.
ASPHO Recognizes Pediatric Hematologist-Oncologists at Annual Meeting | Blood Cancers Today
The awards recognize early-, mid-, or senior-career experts who display excellence in the field of pediatric hematology/oncology.
The HemOnc Pulse Live | Blood Cancers Today
The second annual HemOnc Pulse Live will address unanswered questions in hematologic malignancies May 2-3 in Austin, Texas.